CN104215479A - Biology test method for rapidly detecting comprehensive toxicity of traditional Chinese medicine injection - Google Patents
Biology test method for rapidly detecting comprehensive toxicity of traditional Chinese medicine injection Download PDFInfo
- Publication number
- CN104215479A CN104215479A CN201310210195.8A CN201310210195A CN104215479A CN 104215479 A CN104215479 A CN 104215479A CN 201310210195 A CN201310210195 A CN 201310210195A CN 104215479 A CN104215479 A CN 104215479A
- Authority
- CN
- China
- Prior art keywords
- test
- liquid
- titer
- sodium chloride
- testing according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 231100000419 toxicity Toxicity 0.000 title claims abstract description 25
- 230000001988 toxicity Effects 0.000 title claims abstract description 25
- 238000010998 test method Methods 0.000 title claims abstract 12
- 238000002347 injection Methods 0.000 title abstract description 50
- 239000007924 injection Substances 0.000 title abstract description 50
- 238000012360 testing method Methods 0.000 claims abstract description 58
- 239000000243 solution Substances 0.000 claims abstract description 44
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 36
- 241000894006 Bacteria Species 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims abstract description 23
- 238000010790 dilution Methods 0.000 claims abstract description 21
- 239000012895 dilution Substances 0.000 claims abstract description 21
- 230000005764 inhibitory process Effects 0.000 claims abstract description 19
- 239000011780 sodium chloride Substances 0.000 claims abstract description 18
- 238000011084 recovery Methods 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 19
- 238000001514 detection method Methods 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 230000001717 pathogenic effect Effects 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims 5
- 241000607565 Photobacterium phosphoreum Species 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 31
- 241000607620 Aliivibrio fischeri Species 0.000 description 15
- 239000003085 diluting agent Substances 0.000 description 13
- 240000000691 Houttuynia cordata Species 0.000 description 12
- 235000013719 Houttuynia cordata Nutrition 0.000 description 12
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 11
- 244000020518 Carthamus tinctorius Species 0.000 description 11
- 230000001580 bacterial effect Effects 0.000 description 10
- 239000012086 standard solution Substances 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 8
- 239000012085 test solution Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 238000011835 investigation Methods 0.000 description 4
- 238000003908 quality control method Methods 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 231100000820 toxicity test Toxicity 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000758769 Houttuynia Species 0.000 description 1
- 235000013717 Houttuynia Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000607568 Photobacterium Species 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 239000008923 Qingkailing Substances 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- -1 fingerprints Polymers 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000011867 re-evaluation Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000009254 shuang-huang-lian Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000008865 yin zhi huang Substances 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种快速检测中药注射剂综合毒性的生物测试方法。The invention relates to a biological testing method for rapidly detecting the comprehensive toxicity of traditional Chinese medicine injections.
背景技术Background technique
中药注射剂在我国已经有70多年的应用历史,对心脑血管、抗肿瘤、呼吸系统等疾病的疗效显著,具有独特的优势,在临床上使用广泛。近年来,随着中药注射剂临床应用的日趋广泛,不良反应报道亦日渐增多。从2006年“葛根素事件”、“鱼腥草事件”到2008年的“刺五加事件”、“茵栀黄事件”,再到2009年的“双黄连事件”和“清开灵事件”,让整个中药注射剂行业陷入信任危机。2006年之后,国家对中药注射剂安全问题的关注达到了前所未有的高度。2009年7月,国家食品药品监管局下发《关于做好中药注射剂安全再评价工作的通知》,全面开展生产及质量控制环节的风险排查切实控制中药注射剂安全隐患。Traditional Chinese medicine injections have been used in my country for more than 70 years. They have remarkable curative effects on diseases such as cardiovascular and cerebrovascular diseases, anti-tumor diseases, and respiratory system. They have unique advantages and are widely used clinically. In recent years, as the clinical application of traditional Chinese medicine injections has become more and more extensive, the reports of adverse reactions have also increased. From the "puerarin incident" and "Houttuynia cordata incident" in 2006 to the "Acanthopanax incident" and "Yinzhihuang incident" in 2008, to the "Shuanghuanglian incident" and "Qingkailing incident" in 2009 , causing the entire Chinese medicine injection industry to fall into a crisis of confidence. After 2006, the state's attention to the safety of traditional Chinese medicine injections has reached an unprecedented height. In July 2009, the State Food and Drug Administration issued the "Notice on Doing a Good Job of Safety Re-evaluation of Traditional Chinese Medicine Injections" to comprehensively carry out risk investigations in the production and quality control links to effectively control the safety hazards of traditional Chinese medicine injections.
目前,中药注射剂质量控制检测的项目包括:性状、鉴别、pH值、重金属、灼炽残渣、有关物质(蛋白质、鞣质、树酯、草酸盐、钾离子)、热原或细菌内毒素、无菌、装量、不溶性微粒、可见异物、含量测定、降压物质、异常毒性、过敏反应检查、溶血与凝聚、渗透压、有害元素、聚山梨酯80、5-HMF、指纹图谱、大分子蛋白检查等。但是,这些检测指标仍然无法有效的保证其药效的一致性和降低其过敏反应的发生率。因此,有必要引入新的质量控制方法。At present, the quality control testing items of traditional Chinese medicine injections include: traits, identification, pH value, heavy metals, burning residues, related substances (proteins, tannins, resins, oxalates, potassium ions), pyrogens or bacterial endotoxins, Sterility, loading, insoluble particles, visible foreign matter, content determination, antihypertensive substances, abnormal toxicity, allergic reaction examination, hemolysis and coagulation, osmotic pressure, harmful elements, polysorbate 80, 5-HMF, fingerprints, macromolecules Protein check, etc. However, these detection indicators still cannot effectively ensure the consistency of its drug effect and reduce the incidence of allergic reactions. Therefore, it is necessary to introduce new quality control methods.
发明内容Contents of the invention
为了解决上述问题,本发明提供了一种快速检测中药注射剂综合毒性的生物测试方法。In order to solve the above problems, the present invention provides a biological testing method for rapidly detecting the comprehensive toxicity of traditional Chinese medicine injections.
本发明快速检测中药注射剂综合毒性的生物测试方法,包括如下步骤:The biological testing method of the present invention rapidly detects the comprehensive toxicity of traditional Chinese medicine injection, comprises the following steps:
(1)制备测试用菌液:取发光细菌冻干粉,用浓度为1~5%(w/v)的氯化钠溶液复苏,得测试用菌液;(1) Preparation of bacterial solution for testing: Take the freeze-dried powder of luminescent bacteria and resuscitate it with a sodium chloride solution with a concentration of 1-5% (w/v) to obtain the bacterial solution for testing;
(2)检测:取待检样品,用测试用菌液检测,确定稀释度-效应动力曲线以及发光强度抑制率为50%的稀释度。(2) Detection: Take the sample to be tested and test it with the test bacterial solution to determine the dilution-effect kinetic curve and the dilution rate at which the luminous intensity inhibition rate is 50%.
稀释度-效应动力曲线,是指待检溶液稀释度与发光强度抑制率的关系曲线。The dilution-effect kinetic curve refers to the relationship curve between the dilution of the solution to be tested and the inhibition rate of luminous intensity.
步骤(1)中,所述发光细菌是费氏弧菌、明亮发光杆菌T3小种、青海弧菌及其它非致病发光细菌。In step (1), the luminescent bacteria are Vibrio fischeri, Photobacterium luminescens race T3, Vibrio qinghai and other non-pathogenic luminescent bacteria.
步骤(1)中,所述制备方法是:取型号为CS234的费氏弧菌冻干粉1支,加入0.2-1.0ml的浓度为3%(w/v)的氯化钠溶液复苏,即得测试用菌液。In step (1), the preparation method is: take 1 Vibrio fischeri freeze-dried powder of model CS234, add 0.2-1.0ml of sodium chloride solution with a concentration of 3% (w/v) to recover, that is Bacteria for testing.
步骤(1)中,所述氯化钠溶液的pH为5~9。In step (1), the pH of the sodium chloride solution is 5-9.
步骤(2)所述检测的方法如下:The detection method described in step (2) is as follows:
a、预测试:取待检样品,用水稀释成5个梯度的待检液,体积百分比分别是:100%、25%、6.25%、1.5625%、0.39%,以1~5%(w/v)的氯化钠溶液为标准液,在所述待测液和标准液中加入测试用菌液,菌液加入量为待检液或标准液体积的1/25~1/15,放置5~30min,检测发光强度,计算5个稀释度的发光度抑制率;a. Pre-test: Take the sample to be tested and dilute it with water into 5 gradients of the solution to be tested. The volume percentages are: 100%, 25%, 6.25%, 1.5625%, 0.39%, with 1~5% (w/v ) sodium chloride solution as the standard solution, add the test bacteria solution to the test solution and the standard solution, the amount of the bacteria solution added is 1/25 to 1/15 of the volume of the test solution or the standard solution, and place it for 5 to 10 minutes. 30min, detect the luminous intensity, and calculate the luminous inhibition rate of 5 dilutions;
b、确定检测稀释度的上限及下限:根据步骤a的结果,以抑制率为90~100%的任一稀释度为上限,若样品原液的抑制率未达到90%,则以样品原液为上限;以抑制率为0~10%的任一稀释度为下限;b. Determine the upper limit and lower limit of the detection dilution: according to the results of step a, take any dilution with an inhibition rate of 90-100% as the upper limit, and if the inhibition rate of the sample stock solution does not reach 90%, use the sample stock solution as the upper limit ; Take any dilution with an inhibition rate of 0 to 10% as the lower limit;
c、测试:在步骤b确定的稀释度上限和下限之间增配6~9个均匀稀释梯度的待检液,以1~5%(w/v)的氯化钠溶液为标准液,在所述待测液和标准液中加入测试用菌液,菌液加入量为待检液或标准液体积的1/25~1/15,放置5~30min,检测发光强度,制作稀释度-效应动力曲线,计算抑制率为50%的稀释度。c. Test: add 6 to 9 uniform dilution gradients of the solution to be tested between the upper and lower limits of the dilution determined in step b, and use 1 to 5% (w/v) sodium chloride solution as the standard solution. Add test bacteria solution to the test solution and standard solution, the amount of bacteria solution added is 1/25 to 1/15 of the volume of the test solution or standard solution, leave it for 5 to 30 minutes, detect the luminous intensity, and make the dilution-effect Kinetic curve, calculation of inhibition rate of 50% dilution.
本发明稀释度,是指待检溶液被冲淡的程度。例如,1ml中药注射液液用3ml水稀释,稀释度为25%。The dilution degree of the present invention refers to the degree to which the solution to be tested is diluted. For example, 1ml of traditional Chinese medicine injection is diluted with 3ml of water, and the dilution is 25%.
如果稀释度的值小,说明待检鱼腥草注射液的毒性大,如果稀释度的值大,说明待检鱼腥草注射液的毒性小。If the value of the dilution degree is small, it means that the toxicity of the Houttuynia cordata injection to be tested is high, and if the value of the dilution degree is large, it means that the toxicity of the Houttuynia cordata injection to be tested is low.
抑制率为50%的稀释度,即本发明EC50。The dilution at which the inhibition rate is 50% is the EC 50 of the present invention.
步骤a和步骤c中,所述待检液中加有氯化钠,其浓度为3%(w/v);所述标准液中氯化钠的浓度为3%(w/v)。In step a and step c, sodium chloride is added to the test solution at a concentration of 3% (w/v); the concentration of sodium chloride in the standard solution is 3% (w/v).
步骤a和步骤c中,所述待检液和标准液的pH为5~9。In step a and step c, the pH of the test solution and the standard solution is 5-9.
步骤a和步骤c中,所述菌液加入量为待检液或标准液体积的1/20。In step a and step c, the added amount of the bacterial solution is 1/20 of the volume of the test solution or standard solution.
步骤a和步骤c中,所述放置时间为15min。In step a and step c, the standing time is 15min.
前述检测方法中,发光强度采用型号为LUMIStox300的生物毒性测试仪检测。In the aforementioned detection method, the luminous intensity is detected by a biotoxicity tester modeled as LUMIStox300.
本发明方法可以有效检测中药注射液的毒性,为其临床应用提供可靠依据,同时,本发明检测方法具有如下优点:(1)检测速度快:在1小时内可以得出结果,评估其综合毒性;(2)操作简单:无需灌胃、静脉注射等专业技术,操作简单,方便易行;(3)反应灵敏;利用现代灵敏的光电检测技术,能对极微弱的光强度变化进行检测,比一般生物细胞反应灵敏几个数量级;(4)能对综合毒性的大小进行判断;(5)细菌样本量大,克服了动物试验中样本数量少以及个体差异等影响。The method of the present invention can effectively detect the toxicity of traditional Chinese medicine injection, and provide a reliable basis for its clinical application. At the same time, the detection method of the present invention has the following advantages: (1) The detection speed is fast: the result can be obtained within 1 hour, and its comprehensive toxicity can be evaluated ; (2) Simple operation: no need for professional techniques such as gavage, intravenous injection, etc., simple operation, convenient and easy; (3) Sensitive response; using modern sensitive photoelectric detection technology, it can detect extremely weak light intensity changes, compared with General biological cells are sensitive to several orders of magnitude; (4) can judge the magnitude of comprehensive toxicity; (5) the large sample size of bacteria overcomes the influence of small sample number and individual differences in animal experiments.
显然,根据本发明的上述内容,按照本领域的普通技术知识和惯用手段,在不脱离本发明上述基本技术思想前提下,还可以做出其它多种形式的修改、替换或变更。Apparently, according to the above content of the present invention, according to common technical knowledge and conventional means in this field, without departing from the above basic technical idea of the present invention, other various forms of modification, replacement or change can also be made.
以下通过实施例形式的具体实施方式,对本发明的上述内容再作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下的实例。凡基于本发明上述内容所实现的技术均属于本发明的范围。The above-mentioned content of the present invention will be further described in detail below through specific implementation in the form of examples. However, this should not be construed as limiting the scope of the above-mentioned subject matter of the present invention to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention.
附图说明Description of drawings
图1浓度1费氏弧菌发光强度随时间的变化图Figure 1 Concentration 1 Vibrio fischeri luminous intensity change with time
图2浓度2费氏弧菌发光强度随时间的变化图Figure 2 Concentration 2 Vibrio fischeri luminous intensity changes with time
图3浓度3费氏弧菌发光强度随时间的变化图Figure 3 Concentration 3 Vibrio fischeri luminous intensity changes with time
图4浓度4费氏弧菌发光强度随时间的变化图Fig. 4 Concentration 4 Vibrio fischeri luminous intensity changing with time
图5浓度5费氏弧菌发光强度随时间的变化图Fig. 5 Concentration 5 Vibrio fischeri luminous intensity change diagram with time
图6鱼腥草注射液样品对费氏弧菌的浓度-效应动力曲线The concentration-effect kinetic curve of Fig. 6 Houttuynia cordata injection sample to Vibrio fischeri
图7鱼腥草注射液样品对费氏弧菌的浓度-效应动力曲线The concentration-effect kinetic curve of Fig. 7 Houttuynia cordata injection sample to Vibrio fischeri
图8红花注射液样品A对费氏弧菌的浓度-效应动力曲线The concentration-effect kinetic curve of Fig. 8 safflower injection sample A to Vibrio fischeri
图9红花注射液样品A对费氏弧菌的浓度-效应动力曲线The concentration-effect kinetic curve of Fig. 9 safflower injection sample A to Vibrio fischeri
图10红花注射液样品B对费氏弧菌的浓度-效应动力曲线The concentration-effect kinetic curve of Fig. 10 safflower injection sample B to Vibrio fischeri
图11红花注射液样品B对费氏弧菌的浓度-效应动力曲线The concentration-effect kinetic curve of Fig. 11 safflower injection sample B to Vibrio fischeri
具体实施方式Detailed ways
实施例1本发明毒性检测方法Embodiment 1 toxicity detection method of the present invention
1实验材料1 Experimental materials
1.1菌种1.1 Strains
费氏弧菌冻干粉(CS234),购自北京滨松光子技术股份有限公司,-20℃避光保存。Freeze-dried powder of Vibrio fischeri (CS234) was purchased from Beijing Hamamatsu Photon Technology Co., Ltd., and stored at -20°C in the dark.
1.2主要试剂1.2 Main reagents
复苏稀释液:3%氯化钠溶液;Resuscitation diluent: 3% sodium chloride solution;
渗透压调节液:20%氯化钠溶液;Osmotic adjustment solution: 20% sodium chloride solution;
中药注射液:鱼腥草注射液剂,市售。Traditional Chinese medicine injection: Houttuynia cordata injection, commercially available.
1.3主要仪器及器材1.3 Main instruments and equipment
LUMIStox300生物毒性测试仪及配套的LUMIStherm预温槽和测试管(Dr.Bruno Lange GmbH)、BCD-539WF电冰箱(海尔)、PB-10酸度计(赛多利斯)LUMIStox300 biological toxicity tester and supporting LUMIStherm preheating tank and test tube (Dr.Bruno Lange GmbH), BCD-539WF refrigerator (Haier), PB-10 acidity meter (Sartorius)
2实验方法2 Experimental methods
2.1测试用菌液的制备2.1 Preparation of bacteria solution for test
从冰箱冷冻室(-20℃)取出费氏弧菌冻干粉1支,置于室温(20℃左右)平衡15min后,加入0.2-1.0ml复苏稀释液,于室温下放置10min,即可用于测试。Take out 1 bottle of Vibrio fischeri freeze-dried powder from the freezer (-20°C) and place it at room temperature (about 20°C) for 15 minutes to equilibrate, then add 0.2-1.0ml recovery diluent and place it at room temperature for 10 minutes, then it can be used test.
2.2预试验2.2 Pre-test
将中药注射剂用蒸馏水按1:4稀释成5个浓度梯度(即稀释度梯度):100%、25%、6.25%、1.5625%、0.39%,按2.3所述制备成待测样品溶液,按2.5所述方法粗测一遍,确定上限及下限的浓度(即稀释度)范围。上限为抑制率达到90~100%时样品的浓度,若样品原液的抑制率未达到90%,则以样品原液为上限;下限为抑制率达到0~10%时样品的浓度。Dilute the traditional Chinese medicine injection with distilled water according to 1:4 into 5 concentration gradients (i.e. dilution gradient): 100%, 25%, 6.25%, 1.5625%, 0.39%, prepare the sample solution to be tested according to 2.3, and prepare according to 2.5 The method is roughly tested once to determine the concentration (ie dilution) range of the upper limit and the lower limit. The upper limit is the concentration of the sample when the inhibition rate reaches 90-100%. If the inhibition rate of the sample stock solution does not reach 90%, the sample stock solution is taken as the upper limit; the lower limit is the concentration of the sample when the inhibition rate reaches 0-10%.
2.3待测样品溶液制备2.3 Preparation of sample solution to be tested
在上限和下限之间根据需要再增配6~12个浓度。将样品用蒸馏水稀释到各浓度,再将各浓度样品与渗透压调节液以17:3的比例混合,配制成待测样品溶液,使待测样品溶液NaCl浓度为3%。Between the upper limit and the lower limit, add 6 to 12 concentrations as needed. Dilute the sample with distilled water to each concentration, and then mix the samples of each concentration with the osmotic pressure adjustment solution at a ratio of 17:3 to prepare the sample solution to be tested, so that the NaCl concentration of the sample solution to be tested is 3%.
2.4空白对照液(标准液)制备2.4 Preparation of blank control solution (standard solution)
采用复苏稀释液作为空白对照液。The recovery diluent was used as the blank control solution.
2.5发光强度测定2.5 Measurement of Luminous Intensity
待测样品每个浓度准备3支测试管,每支测试管加入1ml待测样品,设3个平行样;空白对照液也取3支测试管,每支测试管加入1ml复苏稀释液,同样设置3个平行样。用移液器向各测试管中依次加入0.05ml测试用菌液,轻轻振荡,使之充分混匀,每个测试管加菌液的间隔时间为15秒,于育温槽中放置15min后用生物毒性测试仪依次间隔15秒测定各测试管的发光强度,按下式计算抑制率,以EC50(抑制率等于50%时该样品的浓度值)表示各样品的毒性大小,EC50值越小,毒性越大。Prepare 3 test tubes for each concentration of the sample to be tested, add 1ml of the sample to be tested in each test tube, and set up 3 parallel samples; take 3 test tubes for the blank control solution, add 1ml of recovery diluent to each test tube, and set the same 3 parallel samples. Use a pipette to add 0.05ml test bacteria solution to each test tube in turn, shake gently to make it fully mixed, the interval between adding bacteria solution to each test tube is 15 seconds, and place it in the incubation tank for 15 minutes Use a biological toxicity tester to measure the luminous intensity of each test tube at intervals of 15 seconds, calculate the inhibition rate according to the following formula, and express the toxicity of each sample with EC 50 (the concentration value of the sample when the inhibition rate is equal to 50%), and the EC 50 value The smaller it is, the more toxic it is.
2.6方法学考察2.6 Methodological investigation
2.6.1测定方法影响因素考察2.6.1 Investigation of influencing factors of determination method
2.6.1.1时间对发光强度的影响2.6.1.1 Effect of time on luminous intensity
测试管中加入不同体积的复苏稀释液和测试用菌液,制备成不同初始发光强度的测试样品(总体积为1.05ml,样品1为1.04ml复苏稀释液加入0.01ml测试用菌液,样品2为1.02ml复苏稀释液加入0.03ml测试用菌液,样品3为1.00ml复苏稀释液加入0.05ml测试用菌液,样品4为0.95ml复苏稀释液加入0.1ml测试用菌液,样品5为0.85ml复苏稀释液加入0.2ml测试用菌液),轻轻振荡,使之充分混匀,每组样品做3个平行样。从混匀开始计时,每1分钟测定1次发光强度值,算出3个平行样的平均值,比较时间对不同初始发光强度的影响。Add different volumes of resuscitation diluent and test bacterial solution to the test tube to prepare test samples with different initial luminous intensities (total volume is 1.05ml, sample 1 is 1.04ml resuscitative diluent plus 0.01ml test bacterial solution, sample 2 Add 0.03ml test bacteria solution to 1.02ml resuscitation diluent, add 0.05ml test bacteria solution to 1.00ml resuscitation diluent for sample 3, add 0.1ml test bacteria solution to 0.95ml resuscitation diluent, sample 5 is 0.85 Add 0.2ml test bacterial solution to 0.2ml resuscitation diluent), shake gently to make it fully mixed, and make 3 parallel samples for each group of samples. Start timing from mixing, measure the luminous intensity value every 1 minute, calculate the average value of 3 parallel samples, and compare the influence of time on different initial luminous intensities.
2.6.1.2pH值对发光强度的影响2.6.1.2 Effect of pH value on luminous intensity
取复苏稀释液加入NaOH或HCl,分别配成pH为3,4,5,6,7,8,9,10,11的复苏稀释液。分别取各pH值复苏稀释液1ml于测试管中(每组做3个平行样),向各测试管中依次加入0.05ml测试用菌液,轻轻振荡,使之充分混匀,分别于放置5min,10min,15min后用生物毒性测试仪测定发光强度值,比较pH值对发光强度的影响。Take the recovery diluent and add NaOH or HCl to prepare the recovery diluents with pHs of 3, 4, 5, 6, 7, 8, 9, 10, and 11, respectively. Take 1ml of recovery diluent for each pH value in the test tube (3 parallel samples for each group), add 0.05ml test bacteria solution to each test tube in turn, shake gently to make it fully mixed, and place in After 5 min, 10 min, and 15 min, measure the luminous intensity value with a biotoxicity tester, and compare the influence of pH value on the luminous intensity.
2.6.2精密度考察2.6.2 Inspection of precision
2.6.2.1重复性考察2.6.2.1 Repeatability inspection
按上述确定的方法对3批中药注射剂样品(KZ-110501、KZ-110502、KZ-110503)进行测试、每批样品重复3次试验,对结果进行评价。Three batches of Chinese medicine injection samples (KZ-110501, KZ-110502, KZ-110503) were tested according to the method determined above, and the test was repeated 3 times for each batch of samples, and the results were evaluated.
2.6.2.2中间精密度考察2.6.2.2 Intermediate precision inspection
(1)不同人员试验(1) Experiments with different personnel
按上述确定的方法,由两个工作人员在同一工作日对同一批中药注射剂样品(KZ-110503)进行测试,对结果进行评价。According to the method determined above, two staff members tested the same batch of traditional Chinese medicine injection samples (KZ-110503) on the same working day, and evaluated the results.
(2)不同工作日试验(2) Tests on different working days
按上述确定的方法,由同一工作人员在不同工作日对同一批中药注射剂样品(KZ-110503)进行测试,对结果进行评价。According to the method determined above, the same batch of traditional Chinese medicine injection samples (KZ-110503) were tested by the same staff on different working days, and the results were evaluated.
3结果3 results
3.1测定方法影响因素考察3.1 Investigation of influencing factors of determination method
3.1.1时间对发光强度的影响3.1.1 Effect of time on luminous intensity
实验结果如表1和图1所示:The experimental results are shown in Table 1 and Figure 1:
表1时间对不同初始发光强度的影响 Table 1 Effect of time on different initial luminous intensities
由表1和图1~5可见,5个样品的发光强度值随时间的延长呈降低趋势,在5~30min内维持于一个相对稳定的水平,初始发光强度值越高,发光强度降低率越低。同时,实验发现,15min发光强度为500-1000时(样品3),检测结果较准确,成本也交低,因此,测试用菌液的加入量优选为菌液体积的1/20。It can be seen from Table 1 and Figures 1 to 5 that the luminous intensity values of the five samples showed a decreasing trend with the prolongation of time, and remained at a relatively stable level within 5 to 30 minutes. Low. At the same time, the experiment found that when the luminous intensity in 15 minutes is 500-1000 (sample 3), the detection result is more accurate and the cost is also low. Therefore, the amount of bacterial liquid used for testing is preferably 1/20 of the volume of the bacterial liquid.
3.1.2pH值对发光强度的影响3.1.2 Effect of pH value on luminous intensity
实验结果如表2所示:The experimental results are shown in Table 2:
表2pH值对发光强度的影响 The influence of table 2pH value on luminous intensity
由表2可见,检测时,溶液pH值在5.0-9.0之间对发光强度的影响较小,抑制率在±10%之内,因此使用本发明检测方法检测时,溶液pH优选为5.0~9.0。It can be seen from Table 2 that during detection, the pH value of the solution between 5.0-9.0 has little influence on the luminous intensity, and the inhibition rate is within ±10%. Therefore, when the detection method of the present invention is used for detection, the pH value of the solution is preferably 5.0-9.0 .
3.2精密度考察3.2 Inspection of precision
3.2.1重复性试验3.2.1 Repeatability test
实验结果如表3和表4所示:The experimental results are shown in Table 3 and Table 4:
表3重复性试验结果Table 3 Repeatability test results
表43批中药注射剂样品EC50值(%)Table 43 batches of traditional Chinese medicine injection samples EC 50 value (%)
由表3和表4可见,本发明方法的重复性试验的相对偏差<15%,说明本发明方法的准确度高,可重复性好。As seen from Table 3 and Table 4, the relative deviation<15% of the repeatability test of the inventive method shows that the inventive method has high accuracy and good repeatability.
3.2.2中间精密度考察3.2.2 Intermediate precision inspection
3.2.2.1不同工作人员试验3.2.2.1 Different staff experiments
表5不同工作人员试验结果Table 5 Test results of different workers
3.2.2.2不同工作日试验3.2.2.2 Tests on different working days
表6不同工作日试验结果Table 6 Test results on different working days
由表5和表6可见,本发明方法中间精密度试验的相对偏差<15%,说明本发明方法的再现性好,准确度高。As seen from Table 5 and Table 6, the relative deviation <15% of the intermediate precision test of the inventive method shows that the reproducibility of the inventive method is good and the accuracy is high.
实验说明,本发明方法可以有效检测中药注射液的毒性,可重复性好,再现性好,准确度高。Experiments show that the method of the invention can effectively detect the toxicity of the traditional Chinese medicine injection, and has good repeatability, good reproducibility and high accuracy.
实施例2应用本发明对两种中药注射液进行综合毒性测试Embodiment 2 application of the present invention carries out comprehensive toxicity test to two kinds of Chinese medicine injections
1实验材料1 Experimental materials
同实施例1。With embodiment 1.
中药注射液:鱼腥草注射液,红花注射液,市售。Traditional Chinese medicine injection: Houttuynia cordata injection, safflower injection, commercially available.
1.3主要仪器及器材1.3 Main instruments and equipment
同实施例1。With embodiment 1.
2实验方法2 Experimental methods
鱼腥草注射液、红花注射液均经传统方法检测,确定为合格产品。Both Houttuynia cordata injection and safflower injection were tested by traditional methods and were determined to be qualified products.
采用实施例1的方法,对鱼腥草注射液和红花注射液进行发光强度测定,计算抑制率,用EC50比较各样品的综合毒性大小。Using the method of Example 1, the luminous intensity of Houttuynia cordata injection and safflower injection was measured, the inhibition rate was calculated, and the comprehensive toxicity of each sample was compared with EC50 .
2.1测试用菌液的制备2.1 Preparation of test bacterial solution
同实施例1。With embodiment 1.
2.2预试验2.2 Pre-test
同实施例1。With embodiment 1.
2.3待测样品溶液制备2.3 Preparation of sample solution to be tested
同实施例1。With embodiment 1.
2.4空白对照液制备2.4 Preparation of blank control solution
同实施例1。With embodiment 1.
2.5发光强度测定2.5 Measurement of Luminous Intensity
同实施例1。With embodiment 1.
3结果3 results
3.1鱼腥草注射液综合毒性测试3.1 Comprehensive Toxicity Test of Houttuynia Injection
表7鱼腥草注射液样品综合毒性结果Table 7 Comprehensive toxicity results of Houttuynia cordata injection samples
由表7和图6~7可以看出,鱼腥草注射液样品A的EC50(发光强度抑制率为50%时的稀释度)低于鱼腥草注射液样品B的EC50,说明前者的毒性大于后者的毒性。It can be seen from Table 7 and Figures 6-7 that the EC 50 (dilution when the luminescence intensity inhibition rate is 50%) of Houttuynia cordata injection sample A is lower than the EC 50 of Houttuynia cordata injection sample B, indicating that the former The toxicity of is greater than that of the latter.
3.2红花注射液综合毒性测试3.2 Comprehensive toxicity test of safflower injection
表8红花注射液样品综合毒性结果Table 8 Comprehensive toxicity results of safflower injection samples
由表8以及图8~11可以看出,红花注射液样品A的EC50(发光强度抑制率为50%时的稀释度)低于红花注射液样品B的EC50,说明前者的毒性大于后者的毒性。It can be seen from Table 8 and Figures 8-11 that the EC 50 (dilution when the luminous intensity inhibition rate is 50%) of safflower injection sample A is lower than the EC 50 of safflower injection sample B, indicating the toxicity of the former more toxic than the latter.
实验说明,对于用传统方法检测质量均合格的中药注射液,本发明方可以测出其毒性有大有小,能够较好地解释现有中药注射液不良反应不一致的现象。Experiments show that, for traditional Chinese medicine injections whose quality is qualified by traditional methods, the invention can detect whether the toxicity is large or small, and can better explain the inconsistent phenomenon of adverse reactions of existing Chinese medicine injections.
综上,本发明毒性检测方法的检测速度快,操作简单,反应灵敏,准确度高,可以检测中药注射液的毒性,为中药注射液的质量控制提供依据,应用前景良好。In summary, the toxicity detection method of the present invention has fast detection speed, simple operation, sensitive response and high accuracy, can detect the toxicity of traditional Chinese medicine injections, provides a basis for quality control of traditional Chinese medicine injections, and has a good application prospect.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310210195.8A CN104215479B (en) | 2013-05-30 | 2013-05-30 | A kind of biological test method of quick detection Chinese medicine comprehensive toxicity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310210195.8A CN104215479B (en) | 2013-05-30 | 2013-05-30 | A kind of biological test method of quick detection Chinese medicine comprehensive toxicity |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104215479A true CN104215479A (en) | 2014-12-17 |
CN104215479B CN104215479B (en) | 2016-12-28 |
Family
ID=52097201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310210195.8A Active CN104215479B (en) | 2013-05-30 | 2013-05-30 | A kind of biological test method of quick detection Chinese medicine comprehensive toxicity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104215479B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105973875A (en) * | 2016-04-27 | 2016-09-28 | 四川省中医药科学院 | Quality control method for drug microtox assay system |
CN107091833A (en) * | 2017-05-02 | 2017-08-25 | 北京大学 | A kind of method of Fast Evaluation petroleum polluted soil ecology toxicity |
CN107643371A (en) * | 2017-09-13 | 2018-01-30 | 广州瑞森生物科技股份有限公司 | A kind of method for building up of edible agricultural product quality and safety risk evaluation model |
CN108627503A (en) * | 2017-05-05 | 2018-10-09 | 四川省中医药科学院 | A kind of bilobalide injection quality determining method |
CN110607340A (en) * | 2019-10-08 | 2019-12-24 | 四川大学 | A kind of detection method of leather comprehensive toxicity |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101560491A (en) * | 2008-04-15 | 2009-10-21 | 中国科学院上海生命科学研究院 | Luminous bacteria and application thereof in detecting general biological toxicity in food or water sample |
CN102364330A (en) * | 2011-08-31 | 2012-02-29 | 宇星科技发展(深圳)有限公司 | Water quality detection method |
CN102634564A (en) * | 2012-04-17 | 2012-08-15 | 上海海洋大学 | Method for detecting toxicity of antibiotic-type substances by utilizing luminous bacteria |
-
2013
- 2013-05-30 CN CN201310210195.8A patent/CN104215479B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101560491A (en) * | 2008-04-15 | 2009-10-21 | 中国科学院上海生命科学研究院 | Luminous bacteria and application thereof in detecting general biological toxicity in food or water sample |
CN102364330A (en) * | 2011-08-31 | 2012-02-29 | 宇星科技发展(深圳)有限公司 | Water quality detection method |
CN102634564A (en) * | 2012-04-17 | 2012-08-15 | 上海海洋大学 | Method for detecting toxicity of antibiotic-type substances by utilizing luminous bacteria |
Non-Patent Citations (4)
Title |
---|
孟庆义: "人参皂苷等中药对发光细菌发光的淬灭作用", 《中国中西医结合杂志》 * |
张国辉等: "发光弧菌快速检测液态奶中的三聚氰胺", 《食品科学》 * |
李翔等: "黄曲霉毒素对费氏弧菌发光的影响", 《微生物学报》 * |
杨安泰等: "用发光细菌研究中药"十八反"", 《上海中医药杂志》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105973875A (en) * | 2016-04-27 | 2016-09-28 | 四川省中医药科学院 | Quality control method for drug microtox assay system |
CN105973875B (en) * | 2016-04-27 | 2021-06-25 | 四川省中医药科学院 | A kind of quality control method of drug microtoxicity test system |
CN107091833A (en) * | 2017-05-02 | 2017-08-25 | 北京大学 | A kind of method of Fast Evaluation petroleum polluted soil ecology toxicity |
CN108627503A (en) * | 2017-05-05 | 2018-10-09 | 四川省中医药科学院 | A kind of bilobalide injection quality determining method |
CN108627503B (en) * | 2017-05-05 | 2021-03-02 | 四川省中医药科学院 | Method for detecting quality of ginkgolide injection |
CN107643371A (en) * | 2017-09-13 | 2018-01-30 | 广州瑞森生物科技股份有限公司 | A kind of method for building up of edible agricultural product quality and safety risk evaluation model |
CN107643371B (en) * | 2017-09-13 | 2020-08-07 | 广州瑞森生物科技股份有限公司 | Method for establishing edible agricultural product quality safety risk assessment model |
CN110607340A (en) * | 2019-10-08 | 2019-12-24 | 四川大学 | A kind of detection method of leather comprehensive toxicity |
CN110607340B (en) * | 2019-10-08 | 2023-07-25 | 四川大学 | A method for detecting comprehensive toxicity of crust leather |
Also Published As
Publication number | Publication date |
---|---|
CN104215479B (en) | 2016-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104215479B (en) | A kind of biological test method of quick detection Chinese medicine comprehensive toxicity | |
CN103868916B (en) | Biological test method for rapidly detecting comprehensive toxicity of traditional Chinese medicine | |
CN101979544A (en) | A relative calibration method for real-time fluorescent PCR based on standard samples | |
CN108195785A (en) | The detection method of free amino acid in a kind of water-soluble fertilizer | |
WO2022100040A1 (en) | Method and device for detecting specific protein reaction | |
CN103424401B (en) | A kind of biological test method of quick detection houttuynia cordata injection comprehensive toxicity | |
CN104359901A (en) | Rapid detecting method for hydroxymethyl furfural in honey | |
CN104132939A (en) | Method for rapidly detecting amylase value in honey | |
CN103675278A (en) | Carbohydrate antigen-125 quantitative determination kit and application thereof | |
CN104181117A (en) | Method for detecting content of protein in fiber | |
CN104089947A (en) | Method for detecting chemical components comprising nickel, chromium and manganese of stainless steel | |
CN104698159B (en) | A kind of detection method of endotoxin content | |
CN103115881B (en) | Evaluate and reduce the method for the uncertainty numerical value of potassium in iron ore | |
CN102692494B (en) | Endotoxin detection method for nano-particle size analyzer | |
Chen et al. | A new criteria for screening macroprolactinemia using polyethylene glycol treatment combined with different assays for prolactin. | |
CN103868915B (en) | A kind of biological test method of quick detection Flos Carthami injection comprehensive toxicity | |
CN105973875B (en) | A kind of quality control method of drug microtoxicity test system | |
CN106124714B (en) | For the sulfur dioxide on-line monitoring method and device during wine production | |
CN106092989B (en) | A method for quantifying heparin by counting the agglomeration ratio of quantum dots | |
CN101782509B (en) | Cytoactive detection method based on capillary zone electrophoresis mode | |
CN104266892A (en) | Method for testing total nitrogen in tobacco by using hydrogen peroxide instead of mercuric oxide | |
CN104880442B (en) | A kind of method for determining Dopamine hydrochloride | |
CN104237229A (en) | Ph value testing liquid and preparation method thereof | |
CN109097453A (en) | A kind of RNA nucleic acid definite value Quality Control object and preparation method thereof | |
Daya | Funnel plots and publication bias–work in progress? |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |